West Pharmaceutical Services, Inc. (WST)

NYSE: WST · Real-Time Price · USD

Compare

246.16

+2.60 (1.07%)

At close: Feb 11, 2026, 4:00 PM EST

245.10

-1.06 (-0.43%)

After-hours: Feb 11, 2026, 7:45 PM EST

WST Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 11, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	17,710	23,723	26,053	17,424	34,744	20,944
Market Cap Growth	-29.14%	-8.95%	49.53%	-49.85%	65.89%	88.30%
Enterprise Value	17,384	23,540	25,461	16,995	34,372	20,754
Last Close Price	246.16	326.20	349.82	233.27	463.74	279.57
PE Ratio	36.46	48.15	43.91	29.74	52.50	60.50
Forward PE	32.95	45.90	42.23	34.84	53.55	58.12
PS Ratio	5.91	8.20	8.83	6.04	12.27	9.76
PB Ratio	5.80	8.84	9.04	6.49	14.88	11.29
P/TBV Ratio	6.04	9.25	9.45	6.81	15.78	12.23
P/FCF Ratio	46.71	85.83	62.86	39.65	105.09	70.26
P/OCF Ratio	25.53	36.31	33.55	24.07	59.49	44.33
PEG Ratio	2.74	5.25	5.39	2.31	2.37	3.06
EV/Sales Ratio	5.76	8.14	8.63	5.89	12.14	9.67
EV/EBITDA Ratio	21.69	31.43	30.19	19.22	38.58	39.03
EV/EBIT Ratio	27.32	39.66	36.05	22.25	44.72	49.11
EV/FCF Ratio	45.86	85.17	61.43	38.68	103.97	69.62
Debt / Equity Ratio	0.10	0.11	0.11	0.12	0.14	0.18
Debt / EBITDA Ratio	0.36	0.39	0.35	0.35	0.36	0.60
Debt / FCF Ratio	0.80	1.11	0.75	0.72	0.98	1.11
Net Debt / Equity Ratio	-0.11	-0.07	-0.19	-0.21	-0.19	-0.15
Net Debt / EBITDA Ratio	-0.41	-0.24	-0.65	-0.65	-0.49	-0.53
Net Debt / FCF Ratio	-0.86	-0.65	-1.31	-1.31	-1.32	-0.95
Asset Turnover	0.78	0.77	0.79	0.83	0.93	0.84
Inventory Turnover	4.63	4.67	4.28	4.41	4.73	4.95
Quick Ratio	2.02	1.93	2.07	2.73	2.13	1.99
Current Ratio	2.87	2.80	2.88	3.70	2.93	2.73
Return on Equity (ROE)	16.95%	17.71%	21.32%	23.34%	31.59%	20.20%
Return on Assets (ROA)	10.22%	9.93%	11.86%	13.78%	15.73%	10.29%
Return on Invested Capital (ROIC)	18.60%	20.14%	26.35%	31.89%	38.14%	23.03%
Return on Capital Employed (ROCE)	18.30%	19.20%	22.40%	24.70%	28.30%	18.50%
Earnings Yield	2.78%	2.08%	2.28%	3.36%	1.91%	1.65%
FCF Yield	2.14%	1.17%	1.59%	2.52%	0.95%	1.42%
Dividend Yield	0.36%	0.25%	0.22%	0.31%	0.15%	0.23%
Payout Ratio	12.74%	12.00%	9.61%	9.23%	7.72%	13.89%
Buyback Yield / Dilution	1.55%	2.13%	0.66%	0.66%	-0.66%	-0.53%
Total Shareholder Return	1.91%	2.37%	0.88%	0.97%	-0.51%	-0.30%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q